Alerts will be sent to your verified email
Verify Email
SUDARSHAN
|
Sudarshan Pharma Ind
|
Kilitch Drugs(India)
|
Kopran
|
|
|---|---|---|---|
|
Operational Metrics
|
|||
|
Financials
|
|||
|
5 yr Average ROE
|
11.77 % | 4.81 % | 13.42 % |
|
5yr average Equity Multiplier
|
3.38 | 1.42 | 1.63 |
|
5yr Average Asset Turnover Ratio
|
1.89 | 0.51 | 0.91 |
|
5yr Avg Net Profit Margin
|
2.0 % | 6.07 % | 8.88 % |
|
Price to Book
|
5.68 | 3.74 | 1.47 |
|
P/E
|
46.85 | 26.98 | 21.76 |
|
5yr Avg Cash Conversion Cycle
|
121.83 Days | -7.56 Days | 93.5 Days |
|
Inventory Days
|
54.87 Days | 17.9 Days | 83.24 Days |
|
Days Receivable
|
102.16 Days | 138.92 Days | 111.32 Days |
|
Days Payable
|
70.3 Days | 199.26 Days | 87.92 Days |
|
5yr Average Interest Coverage Ratio
|
2.61 | 5.07 | 10.26 |
|
5yr Avg ROCE
|
23.07 % | 8.16 % | 18.18 % |
|
5yr Avg Operating Profit Margin
|
4.55 % | 9.07 % | 13.87 % |
|
5 yr average Debt to Equity
|
0.99 | 0.14 | 0.26 |
|
5yr CAGR Net Profit
|
42.99 % | 77.02 % | 19.38 % |
|
5yr Average Return on Assets
|
3.51 % | 3.38 % | 8.15 % |
|
Shareholdings
|
|||
|
Promoter Holding
|
57.39 % | 69.23 % | 44.42 % |
|
Share Pledged by Promoters
|
0.0 | 0.0 | 0.0 |
|
Change in Promoter Holding (3 Yrs)
|
-31.89 % | 0.98 % | 0.17 % |
|
Change in Mutual Fund Holding (3 Yrs)
|
0.0 | 0.0 | 0.0 |
|
Sudarshan Pharma Ind
|
Kilitch Drugs(India)
|
Kopran
|
|
|---|---|---|---|
|
Product Wise Break-Up
|
Product Wise Break-Up
|
Product Wise Break-Up
|
Product Wise Break-Up
|
|
Location Wise Break-Up
|
Location Wise Break-Up
|
Location Wise Break-Up
|
Location Wise Break-Up
|